May 13, 2023 by James HalleyIs CRISPR Therapeutics Stock a Buy Now?The clinical-stage biotech company has been on the rise.
May 12, 2023 by James HalleyWhy Shares of Cassava Sciences Jumped This WeekCassava Sciences finished dosing in one of its phase 3 trials for its Alzheimer's therapy Simufilam.
May 12, 2023 by James HalleyWhy Shares of Cytek Biosciences Dropped This WeekCytek grew revenue and losses in the first quarter.
May 12, 2023 by James HalleyWhy Shares of Harrow Health Are Slumping FridayThe pharmaceutical company announced first-quarter earnings Thursday afternoon.
May 11, 2023 by James HalleyWhy Guardant Health's Shares Climbed This WeekThe company, which focuses on oncology screenings, saw a big gain in revenue in the first quarter.
May 11, 2023 by James HalleyWhy Shares of DBV Technologies Jumped Thursday"The New England Journal of Medicine" reported phase 3 trial details regarding the company's peanut allergy treatment for toddlers.
May 11, 2023 by James HalleyWhy Shares of Organogenesis Holdings Jumped ThursdayThe company, which specializes in wound care solutions, released first-quarter earnings.
May 11, 2023 by James HalleyWhy Shares of Steris Are Up ThursdayThe medical equipment company closed its fiscal year with a strong quarter.
May 10, 2023 by James HalleyWhy Shares of Exact Sciences Rose on WednesdayThe diagnostic testing company announced strong first-quarter earnings.
May 10, 2023 by James HalleyWhy Shares of MannKind Are Up WednesdayThe company released its first-quarter earnings report on Tuesday.
May 10, 2023 by James HalleyWhy Shares of CTI BioPharma Are Soaring WednesdayA buyout offer from Swedish Orphan Biovitrum drove up the stock's price.
May 9, 2023 by James HalleyWhy Shares of Grifols Were Up TuesdayThe company gave first-quarter numbers.
May 9, 2023 by James HalleyWhy Shares of DaVita Were Up TuesdayThe dialysis company's raised guidance encouraged investors.
May 9, 2023 by James Halley3 Best Marijuana Stocks to Buy in MayThese companies' shares are faring better than most cannabis stocks this year.
May 7, 2023 by James Halley2 Top Healthcare Stocks Defying the Bear MarketThese pharmaceutical companies are expected to see a big rise in revenue, thanks to new therapies.
May 5, 2023 by James HalleyWhy Shares of Summit Therapeutics Soared This WeekSummit Therapeutics advanced its lead therapy into two phase 3 trials to treat non-small cell lung cancer.
May 5, 2023 by James HalleyWhy Shares of Avadel Soared This WeekThe company got its first FDA approval.
May 5, 2023 by James Halley2 Cannabis Stocks to Consider If the SAFE Banking Act PassesThese two multi-state operators have the size and business sense to benefit from national cannabis banking reform.
May 4, 2023 by James HalleyWhy Karyopharm Therapeutics Shares Slumped ThursdayThe company downgraded guidance in its first-quarter report.
May 4, 2023 by James HalleyWhy Shares of Lantheus Holdings Are Up ThursdayThe company reported a record quarter for revenue.
